D65 Disseminated intravascular coagulation [defibrination syndrome]
The ICD-10-CM code for Disseminated intravascular coagulation [defibrination syndrome] is D65 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- D65-D69: Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
- Category D65
- 1 code (1 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to D65:
- Defibrination (syndrome)
- Proteolysis, pathologic
- Fibrinolysis (hemorrhagic) (acquired)
- Coagulation, intravascular (diffuse) (disseminated) › COVID-19 associated
- Coagulopathy › consumption
- Coagulopathy › intravascular
- Fibrinogenopenia › acquired
- Afibrinogenemia › acquired
Inclusion Terms
- Afibrinogenemia, acquired
- Consumption coagulopathy
- COVID-19 associated diffuse or disseminated intravascular coagulopathy
- Diffuse or disseminated intravascular coagulation [DIC]
- Fibrinolytic hemorrhage, acquired
- Fibrinolytic purpura
- Purpura fulminans
U.S. Hospital Utilization
- An estimated 45,520 U.S. inpatient stays in 2023 included D65 among the documented diagnoses.
- 585 stays listed it as the principal diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Chapter 3 TOC entry3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39
Reserved for future guideline expansionReserved for future guideline expansion ...................................................................................... 39
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026